Patho-biological aspects of basal-like breast cancer Emad A. RakhaMaysa E. El-SayedIan O. Ellis Review 09 March 2008 Pages: 411 - 422
Peroxisome proliferator-activated receptor gamma activates fas ligand gene promoter inducing apoptosis in human breast cancer cells Daniela BonofiglioSabrina GabrieleSebastiano Andò Preclinical Study 22 February 2008 Pages: 423 - 434
Anti-cancer effect of hyperthermia on breast cancer by magnetite nanoparticle-loaded anti-HER2 immunoliposomes Toyone KikumoriTakeshi KobayashiTsuneo Imai Preclinical Study 02 March 2008 Pages: 435 - 441
Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells Ke DongRui WangHui-Zhong Zhang Preclinical Study 10 March 2008 Pages: 443 - 456
Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer A. RodyT. KarnM. Kaufmann Preclinical Study 14 March 2008 Pages: 457 - 466
Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients Nan-Yan RaoZhen HuZhi-Ming Shao Preclinical Study 16 March 2008 Pages: 467 - 477
Fifteen-year median follow-up results after neoadjuvant doxorubicin, followed by mastectomy, followed by adjuvant cyclophosphamide, methotrexate, and fluorouracil (CMF) followed by radiation for stage III breast cancer: a phase II trial (CALGB 8944) G. G. KimmickC. CirrincioneOn Behalf of the Cancer and Leukemia Group B Clinical Trial 28 February 2008 Pages: 479 - 490
Estrogen suppression in premenopausal women following 8 weeks of treatment with exemestane and triptorelin versus triptorelin alone Maria Gabriella JannuzzoEnrico Di SalleAkintunde Bello Clinical Trial 11 March 2008 Pages: 491 - 499
HER2 status predicts the presence of circulating tumor cells in patients with operable breast cancer Julie E. LangKailash MosalpuriaAnthony Lucci Clinical Trial 09 March 2008 Pages: 501 - 507
PET-based estradiol challenge as a predictive biomarker of response to endocrine therapy in women with estrogen-receptor-positive breast cancer Farrokh DehdashtiJoanne E. MortimerBarry A. Siegel Clinical Trial 09 March 2008 Pages: 509 - 517
Apolipoprotein D predicts adverse outcome in women ≥70 years with operable breast cancer Håvard SøilandEmiel A. M. JanssenJon Arne Søreide Clinical Trial 11 March 2008 Pages: 519 - 528
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy Winnie YeoF. K. F. MoB. Zee Clinical Trial 10 March 2008 Pages: 529 - 535
Validation of the Tenon breast cancer score for predicting non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis: a prospective multicenter study Charles CoutantRoman RouzierEmmanuel Barranger Clinical Trial 14 March 2008 Pages: 537 - 543
Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families María J. GarcíaVictoria FernándezJavier Benítez Epidemiology 27 February 2008 Pages: 545 - 551
Multiparity and the risk of premenopausal breast cancer: different effects across ethnic groups in Singapore Helena M. VerkooijenKaren P. L. YapKee Seng Chia Epidemiology 02 March 2008 Pages: 553 - 558
Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening Lauro BucchiFlavia FocaFabio Falcini Epidemiology 04 March 2008 Pages: 559 - 566
The influence of overweight and insulin resistance on breast cancer risk and tumour stage at diagnosis: a prospective study Anne E. CustTanja StocksPär Stattin Epidemiology 11 March 2008 Pages: 567 - 576
Conservative surgery in patients with multifocal/multicentric breast cancer Oreste GentiliniEdoardo BotteriUmberto Veronesi Epidemiology 11 March 2008 Pages: 577 - 583
A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk Chunyan HeRulla M. TamimiJiali Han Epidemiology 14 March 2008 Pages: 585 - 594
Increased racial differences on breast cancer care and survival in America: historical evidence consistent with a health insurance hypothesis, 1975–2001 Kevin M. GoreyIsaac N. LuginaahRenee R. Parsons Brief Report 11 March 2008 Pages: 595 - 600
Surveying germline genomic landscape of breast cancer Kari HemminkiAsta FörstiJusto Lorenzo Bermejo Letter to the editor 24 February 2008 Pages: 601 - 603
BRCA1 2080insA mutation in familial breast cancer Aliya S. AlansariMansour Al-MoundhriShoaib A. Al-Zidjali Letter to the Editor 14 March 2008 Pages: 605 - 606
Evidences for association of the CASP8 -652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases Giovanna De VecchiPaolo VerderioPaolo Peterlongo Letter to the Editor 16 March 2008 Pages: 607 - 608
Life-threatening interstitial lung disease associated with trastuzumab: case report M. J. PepelsK. A. BoomarsP. S. Hupperets Letter to the Editor 16 March 2008 Pages: 609 - 612
